Stanford University
Showing 2,431-2,440 of 12,905 Results
-
Guido A. Davidzon
Clinical Professor, Radiology - Rad/Nuclear Medicine
BioDr. Guido Alejandro Davidzon is a Clinical Professor of Radiology in Nuclear Medicine at the Stanford University School of Medicine. He currently serves as Director of Nuclear Cardiology at Stanford Health Care and is the Chair of the Radioactive Drug Research Committee.
Dr. Davidzon is a physician-scientist, educator, and leader whose work bridges clinical innovation, academic leadership, and translational research. His research focuses on the development and clinical translation of novel radiopharmaceuticals for use in oncology, neurodegeneration, cardiology, and pain imaging. He is also actively integrating AI-driven analytics and machine learning tools into molecular imaging to advance precision diagnostics and therapeutic decision-making.
His clinical and academic efforts include advancing theranostics, PET-based biomarker discovery, and the adoption of emerging imaging technologies in patient care. Dr. Davidzon is deeply committed to mentorship and the training of the next generation of imaging specialists and nuclear medicine professionals. -
Jenna Davis
Professor of Civil and Environmental Engineering, of Environmental Social Sciences and Higgins-Magid Senior Fellow at the Woods Institute
Current Research and Scholarly InterestsProfessor Davis’ research and teaching deals broadly with the role that water plays in promoting public health and economic development, with particular emphasis on low- and middle-income countries. Her group conducts applied research that utilizes theory and analytical methods from public and environmental health, engineering, microeconomics, and planning. They have conducted field research in more than 20 countries, most recently including Zambia, Bangladesh, and Kenya.
-
Kara Davis
Associate Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsChildhood cancers can be considered aberrations of normal tissue development. We are interested in understanding childhood cancers through the lens of normal development. Further, individual tumors are composed of heterogeneous cell populations, not all cells being equal in their ability to respond to treatment or to repopulate a tumor. Thus, we take single cell approach to determine populations of clinical relevance.
